IgA nephropathy in adult-onset Still's disease after tocilizumab treatment: a case report

Int Urol Nephrol. 2022 May;54(5):1167-1168. doi: 10.1007/s11255-021-02956-x. Epub 2021 Jul 16.

Author

Ji-Hyoun Kang¹

Affiliation

¹ Division of Rheumatology, Department of Internal Medicine, Chonnam National University Hospital, 42 Jebong-ro, Dong-gu, Gwangju, 61469, Republic of Korea. romi918@naver.com.

PMID: 34269969
DOI: 10.1007/s11255-021-02956-x

No abstract available

Publication types

Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / adverse effects
Glomerulonephritis, IGA* / complications
Glomerulonephritis, IGA* / drug therapy
Humans
Still's Disease, Adult-Onset* / complications
Still's Disease, Adult-Onset* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
tocilizumab